MurugapoopathyV, GuptaIR: A primer on congenital anomalies of the kidneys and urinary tracts (CAKUT). Clin J Am Soc Nephrol 15: 723–731, 2020PubMed)| false
StonebrookE, HoffM, SpencerJD: Congenital anomalies of the kidney and urinary tract: A clinical review. Curr Treat Options Pediatr5: 223–235, 2019PubMed
RainaR, ChakrabortyR, SethiSK, KumarD, GibsonK, BergmannC: Diagnosis and management of renal cystic disease of the newborn: Core curriculum 2021. Am J Kidney Dis78: 125–141, 2021PubMed
HamiltonAJ, BraddonF, CasulaA, LewisM, MallettT, MarksSD, et al.: UK Renal Registry 19th annual report: Chapter 4 Demography of the UK paediatric renal replacement therapy population in 2015. Nephron137[Suppl 1]: 103–116, 2017PubMed
MartzK, StableinD: North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS), 2008. Available at: https://naprtcs.org/system/files/2008_Annual_CKD_Report.pdf. Accessed February 26, 2024)| false
UK Kidney Association: UK Renal Registry 25th Annual Report, 2023. Available at: https://ukkidney.org/audit-research/annual-report. Accessed February 26, 2024)| false
Subcommittee on Urinary Tract Infection: Reaffirmation of AAP clinical practice guideline: The diagnosis and management of the initial urinary tract infection in febrile infants and young children 2–24 months of age. Pediatrics138: e20163026, 2016PubMed
Subcommittee on Urinary Tract Infection: Reaffirmation of AAP clinical practice guideline: The diagnosis and management of the initial urinary tract infection in febrile infants and young children 2–24 months of age. Pediatrics 138: e20163026, 2016PubMed)| false
TalatiAN, WebsterCM, VoraNL: Prenatal genetic considerations of congenital anomalies of the kidney and urinary tract (CAKUT). Prenat Diagn39: 679–692, 2019PubMed
BonsibSM: Renal hypoplasia, from grossly insufficient to not quite enough: Consideration for expanded concepts based upon the author’s perspective with historical review. Adv Anat Pathol27: 311–330, 2020PubMed
BonsibSM: Renal hypoplasia, from grossly insufficient to not quite enough: Consideration for expanded concepts based upon the author’s perspective with historical review. Adv Anat Pathol 27: 311–330, 2020PubMed)| false
GaffarS, AroraP, RamanathanR: Late preterm infant with postnatal diagnosis of renal tubular dysgenesis. J Investig Med High Impact Case Rep10:10.1177/23247096221111775, 2022PubMed
GaffarS, AroraP, RamanathanR: Late preterm infant with postnatal diagnosis of renal tubular dysgenesis. J Investig Med High Impact Case Rep 10:10.1177/23247096221111775, 2022PubMed)| false
RainaR, HouryA, RathP, MangatG, PandherD, IslamM, et al.: Clinical utility and tolerability of tolvaptan in the treatment of autosomal dominant polycystic kidney disease (ADPKD). Drug Healthc Patient Saf14: 147–159, 2022PubMed
RainaR, HouryA, RathP, MangatG, PandherD, IslamM, : Clinical utility and tolerability of tolvaptan in the treatment of autosomal dominant polycystic kidney disease (ADPKD). Drug Healthc Patient Saf 14: 147–159, 2022PubMed)| false
WalkerEYX, MarlaisM: Should we screen for intracranial aneurysms in children with autosomal dominant polycystic kidney disease?Pediatr Nephrol38: 77–85, 2023PubMed
WalkerEYX, MarlaisM: Should we screen for intracranial aneurysms in children with autosomal dominant polycystic kidney disease? Pediatr Nephrol 38: 77–85, 2023PubMed)| false
MekahliD, Guay-WoodfordLM, CadnapaphornchaiMA, GreenbaumLA, LitwinM, SeemanT, et al.: Tolvaptan for children and adolescents with autosomal dominant polycystic kidney disease: Randomized controlled trial. Clin J Am Soc Nephrol18: 36–46, 2023PubMed
GimpelC, BergmannC, BockenhauerD, BreysemL, CadnapaphornchaiMA, CetinerM, et al.: International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people. Nat Rev Nephrol15: 713–726, 2019PubMed
GimpelC, BergmannC, BockenhauerD, BreysemL, CadnapaphornchaiMA, CetinerM, : International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people. Nat Rev Nephrol 15: 713–726, 2019PubMed)| false
NishimuraH, YerkesE, HohenfellnerK, MiyazakiY, MaJ, HunleyTE, et al.: Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell3: 1–10, 1999PubMed
NishimuraH, YerkesE, HohenfellnerK, MiyazakiY, MaJ, HunleyTE, : Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell 3: 1–10, 1999PubMed)| false
HiraokaM, TaniguchiT, NakaiH, KinoM, OkadaY, TanizawaA, et al.: No evidence for AT2R gene derangement in human urinary tract anomalies. Kidney Int59: 1244–1249, 2001PubMed
HiraokaM, TaniguchiT, NakaiH, KinoM, OkadaY, TanizawaA, : No evidence for AT2R gene derangement in human urinary tract anomalies. Kidney Int 59: 1244–1249, 2001PubMed)| false
MañalichR, ReyesL, HerreraM, MelendiC, FundoraI: Relationship between weight at birth and the number and size of renal glomeruli in humans: A histomorphometric study. Kidney Int58: 770–773, 2000PubMed
MañalichR, ReyesL, HerreraM, MelendiC, FundoraI: Relationship between weight at birth and the number and size of renal glomeruli in humans: A histomorphometric study. Kidney Int 58: 770–773, 2000PubMed)| false
DartAB, RuthCA, SellersEA, AuW, DeanHJ: Maternal diabetes mellitus and congenital anomalies of the kidney and urinary tract (CAKUT) in the child. Am J Kidney Dis65: 684–691, 2015PubMed
DartAB, RuthCA, SellersEA, AuW, DeanHJ: Maternal diabetes mellitus and congenital anomalies of the kidney and urinary tract (CAKUT) in the child. Am J Kidney Dis 65: 684–691, 2015PubMed)| false
GraySP, DentonKM, Cullen-McEwenL, BertramJF, MoritzKM: Prenatal exposure to alcohol reduces nephron number and raises blood pressure in progeny. J Am Soc Nephrol21: 1891–1902, 2010PubMed
Groen In ’t WoudS, RoeleveldN, van RooijIALM, FeitzWFJ, SchreuderMF, van der ZandenLFM; SOFIA study group: Environmental and parental risk factors for congenital solitary functioning kidney - A case-control study. Pediatr Nephrol38: 2631–2641, 2023PubMed
Groen In ’t WoudS, RoeleveldN, van RooijIALM, FeitzWFJ, SchreuderMF, van der ZandenLFM; SOFIA study group: Environmental and parental risk factors for congenital solitary functioning kidney - A case-control study. Pediatr Nephrol 38: 2631–2641, 2023PubMed)| false
van der VenAT, ConnaughtonDM, ItyelH, MannN, NakayamaM, ChenJ, et al.: Whole-exome sequencing identifies causative mutations in families with congenital anomalies of the kidney and urinary tract. J Am Soc Nephrol29: 2348–2361, 2018PubMed
van der VenAT, ConnaughtonDM, ItyelH, MannN, NakayamaM, ChenJ, : Whole-exome sequencing identifies causative mutations in families with congenital anomalies of the kidney and urinary tract. J Am Soc Nephrol 29: 2348–2361, 2018PubMed)| false
KerecukL, SajooA, McGregorL, BergJ, HaqMR, SebireNJ, et al.: Autosomal dominant inheritance of non-syndromic renal hypoplasia and dysplasia: dramatic variation in clinical severity in a single kindred. Nephrol Dial Transplant22: 259–263, 2007PubMed
CraigJC, SimpsonJM, WilliamsGJ, LoweA, ReynoldsGJ, McTaggartSJ, et al.; Prevention of Recurrent Urinary Tract Infection in Children with Vesicoureteric Reflux and Normal Renal Tracts (PRIVENT) Investigators: Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl J Med361: 1748–1759, 2009PubMed
CraigJC, SimpsonJM, WilliamsGJ, LoweA, ReynoldsGJ, McTaggartSJ, ; Prevention of Recurrent Urinary Tract Infection in Children with Vesicoureteric Reflux and Normal Renal Tracts (PRIVENT) Investigators: Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl J Med 361: 1748–1759, 2009PubMed)| false
HobermanA, GreenfieldSP, MattooTK, KerenR, MathewsR, PohlHG, et al.; RIVUR Trial Investigators: Antimicrobial prophylaxis for children with vesicoureteral reflux. N Engl J Med370: 2367–2376, 2014PubMed
HobermanA, GreenfieldSP, MattooTK, KerenR, MathewsR, PohlHG, ; RIVUR Trial Investigators: Antimicrobial prophylaxis for children with vesicoureteral reflux. N Engl J Med 370: 2367–2376, 2014PubMed)| false
Sanna-CherchiS, RavaniP, CorbaniV, ParodiS, HauptR, PiaggioG, et al.: Renal outcome in patients with congenital anomalies of the kidney and urinary tract. Kidney Int76: 528–533, 2009PubMed
Sanna-CherchiS, RavaniP, CorbaniV, ParodiS, HauptR, PiaggioG, : Renal outcome in patients with congenital anomalies of the kidney and urinary tract. Kidney Int 76: 528–533, 2009PubMed)| false
WühlE, van StralenKJ, VerrinaE, BjerreA, WannerC, HeafJG, et al.: Timing and outcome of renal replacement therapy in patients with congenital malformations of the kidney and urinary tract. Clin J Am Soc Nephrol8: 67–74, 2013PubMed
WühlE, van StralenKJ, VerrinaE, BjerreA, WannerC, HeafJG, : Timing and outcome of renal replacement therapy in patients with congenital malformations of the kidney and urinary tract. Clin J Am Soc Nephrol 8: 67–74, 2013PubMed)| false
RitchieAG, ClaytonPA, MackieFE, KennedySE: Nationwide survey of adolescents and young adults with end-stage kidney disease. Nephrology (Carlton)17: 539–544, 2012PubMed
ForbesTA, WatsonAR, ZurowskaA, ShroffR, BakkalogluS, VondrakK, et al.; European Paediatric Dialysis Working Group: Adherence to transition guidelines in European paediatric nephrology units. Pediatr Nephrol29: 1617–1624, 2014PubMed